BioSpace

Roche returns to Hansoh with broad $15B ADC deal

Roche is offering $400 million upfront and over $15 billion in biobucks to team up with Hansoh Pharmaceutical in hopes of developing a portfolio of new antibody-drug conjugates using the latter’s in-house tech.

By BioSpace

1 min read
Roche returns to Hansoh with broad $15B ADC deal
AI-generated illustration

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights